SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $814 | -35.2% | 342,200 | +30.4% | 0.02% | -33.3% |
| Q2 2023 | $1,257 | -15.5% | 262,325 | 0.0% | 0.03% | -17.5% |
| Q1 2023 | $1,487 | +0.2% | 262,325 | -1.0% | 0.04% | -4.8% |
| Q4 2022 | $1,484 | -99.9% | 265,000 | +33.2% | 0.04% | +10.5% |
| Q3 2022 | $1,278,000 | +87.1% | 199,000 | 0.0% | 0.04% | +81.0% |
| Q2 2022 | $683,000 | +53.5% | 199,000 | +218.7% | 0.02% | +75.0% |
| Q1 2022 | $445,000 | -14.4% | 62,450 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $520,000 | +19.5% | 62,450 | 0.0% | 0.01% | +9.1% |
| Q3 2021 | $435,000 | -70.8% | 62,450 | 0.0% | 0.01% | -70.3% |
| Q2 2021 | $1,489,000 | – | 62,450 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |